Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis
Jasmohan S. Bajaj, Alexander Khoruts
Journal of Hepatology (2020) Vol. 72, Iss. 5, pp. 1003-1027
Closed Access | Times Cited: 138

Showing 1-25 of 138 citing articles:

Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders
Daniel M. Chopyk, Arash Grakoui
Gastroenterology (2020) Vol. 159, Iss. 3, pp. 849-863
Open Access | Times Cited: 320
Gut microbiome, liver immunology, and liver diseases
Rui Wang, Ruqi Tang, Bo Li, et al.
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 1, pp. 4-17
Open Access | Times Cited: 303
The microbiota in cirrhosis and its role in hepatic decompensation
Jonel Trebicka, Jane Macnaughtan, Bernd Schnabl, et al.
Journal of Hepatology (2021) Vol. 75, pp. S67-S81
Open Access | Times Cited: 176
Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy
Yasuko Iwakiri, Jonel Trebicka
JHEP Reports (2021) Vol. 3, Iss. 4, pp. 100316-100316
Open Access | Times Cited: 145
Gut microbiota exaggerates triclosan-induced liver injury via gut-liver axis
Peng Zhang, Liyang Zheng, Yitao Duan, et al.
Journal of Hazardous Materials (2021) Vol. 421, pp. 126707-126707
Closed Access | Times Cited: 113
Gut microbiota and metabolites associate with outcomes of immune checkpoint inhibitor–treated unresectable hepatocellular carcinoma
Pei‐Chang Lee, Chi-Jung Wu, Ya‐Wen Hung, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 6, pp. e004779-e004779
Open Access | Times Cited: 105
Promises of microbiome-based therapies
Jasmohan S. Bajaj, Siew C. Ng, Bernd Schnabl
Journal of Hepatology (2022) Vol. 76, Iss. 6, pp. 1379-1391
Open Access | Times Cited: 73
Microbiota transplant for hepatic encephalopathy in cirrhosis: The THEMATIC trial
Jasmohan S. Bajaj, Andrew Fagan, Edith Gavis, et al.
Journal of Hepatology (2025)
Closed Access | Times Cited: 2
Role of gut microbiota via the gut-liver-brain axis in digestive diseases
Jianhong Ding, Zhe Jin, Xiaoxu Yang, et al.
World Journal of Gastroenterology (2020) Vol. 26, Iss. 40, pp. 6141-6162
Open Access | Times Cited: 122
The Use of Rifaximin in Patients With Cirrhosis
Paolo Caraceni, Vı́ctor Vargas, Elsa Solà, et al.
Hepatology (2021) Vol. 74, Iss. 3, pp. 1660-1673
Open Access | Times Cited: 103
The Gut-Liver Axis in Health and Disease: The Role of Gut Microbiota-Derived Signals in Liver Injury and Regeneration
Zhipeng Zheng, Baohong Wang
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 98
Serum Levels of Metabolites Produced by Intestinal Microbes and Lipid Moieties Independently Associated With Acute-on-Chronic Liver Failure and Death in Patients With Cirrhosis
Jasmohan S. Bajaj, K. Rajender Reddy, Jacqueline G. O’Leary, et al.
Gastroenterology (2020) Vol. 159, Iss. 5, pp. 1715-1730.e12
Open Access | Times Cited: 91
Microplastics as an aquatic pollutant affect gut microbiota within aquatic animals
Weixin Li, Xiaofeng Chen, Minqian Li, et al.
Journal of Hazardous Materials (2021) Vol. 423, pp. 127094-127094
Closed Access | Times Cited: 88
Fecal Microbiota Transplantation: A New Therapeutic Attempt from the Gut to the Brain
Haoming Xu, Hong‐Li Huang, Youlian Zhou, et al.
Gastroenterology Research and Practice (2021) Vol. 2021, pp. 1-20
Open Access | Times Cited: 74
The Influence of Nutrition on Intestinal Permeability and the Microbiome in Health and Disease
Orsolya Inczefi, P Bacsúr, Tamás Resál, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 60
The microbiota and the gut–liver axis in primary sclerosing cholangitis
Johannes R. Hov, Tom H. Karlsen
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 3, pp. 135-154
Closed Access | Times Cited: 54
Fecal microbiota transplant improves cognition in hepatic encephalopathy and its effect varies by donor and recipient
Patricia P. Bloom, John Donlan, Mariam Torres Soto, et al.
Hepatology Communications (2022) Vol. 6, Iss. 8, pp. 2079-2089
Open Access | Times Cited: 51
Microbiota of the gastrointestinal tract: Friend or foe?
M. A. Senchukova
World Journal of Gastroenterology (2023) Vol. 29, Iss. 1, pp. 19-42
Open Access | Times Cited: 32
Fecal Microbiota Transplantation in Liver Cirrhosis
Adrian Boicean, Victoria Bîrluțiu, Cristian Ichim, et al.
Biomedicines (2023) Vol. 11, Iss. 11, pp. 2930-2930
Open Access | Times Cited: 29
Bacterial translocation occurs early in cirrhosis and triggers a selective inflammatory response
Benedikt Simbrunner, Esther Caparrós, Teresa Neuwirth, et al.
Hepatology International (2023) Vol. 17, Iss. 4, pp. 1045-1056
Open Access | Times Cited: 25
Gut microbiome-brain-cirrhosis axis
Maren L. Smith, James B. Wade, Jennifer T. Wolstenholme, et al.
Hepatology (2023) Vol. 80, Iss. 2, pp. 465-485
Closed Access | Times Cited: 23
Interaction of bacterial metagenome and virome in patients with cirrhosis and hepatic encephalopathy
Jasmohan S. Bajaj, Masoumeh Sikaroodi, Amirhossein Shamsaddini, et al.
Gut (2020) Vol. 70, Iss. 6, pp. 1162-1173
Closed Access | Times Cited: 67
Chronic Liver Diseases and the Microbiome—Translating Our Knowledge of Gut Microbiota to Management of Chronic Liver Disease
Chathur Acharya, Jasmohan S. Bajaj
Gastroenterology (2020) Vol. 160, Iss. 2, pp. 556-572
Open Access | Times Cited: 66
Protein corona formed in the gastrointestinal tract and its impacts on oral delivery of nanoparticles
Tianxu Zhang, Guanyin Zhu, Boyao Lu, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 3, pp. 1835-1850
Closed Access | Times Cited: 57
Molecular and Cellular Mediators of the Gut-Liver Axis in the Progression of Liver Diseases
Alix Bruneau, Jana Hundertmark, Adrien Guillot, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 53
Page 1 - Next Page

Scroll to top